3
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T14130 | Adomeglivant | LY2409021 | Glucagon Receptor |
Adomeglivant (LY2409021) is a potent and selective glucagon receptor antagonist. Which is used in clinical trial for type 2 diabetes mellitus. | |||
T68472 | Adomeglivant, (+)- | ||
Adomeglivant, (+)-, is a potent and selective glucagon receptor antagonist. LY2409021 lowers blood glucose in healthy people and in those with type 2 diabetes. | |||
T68471 | (+/-)- Adomeglivant | ||
(+/-)- Adomeglivant, also known as LY2409021, is a potent and selective glucagon receptor antagonist. LY2409021 lowers blood glucose in healthy people and in those with type 2 diabetes. Blockade of glucagon signalling in... |